Our Stocks to Watch tomorrow include Seaway Valley Capital Corporation (OTCBB: SWVL), Evolution Fuels Inc. (OTC: EVFL), Luna Innovations Inc. (Nasdaq: LUNA), GoIP Global Inc. (OTC: GOIG), ECOtality Inc. (OTCBB: ETLY) and Stem Cell Therapy International Inc. (OTCBB: SCII).
SEAWAY VALLEY CAPITAL CORPORATION (OTCBB: SWVL)
"Up 100.00% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/SWVL.php
Seaway Valley Capital Corporation invests in equity, equity-related, and debt in companies that require expansion capital and in companies pursuing acquisition strategies. The company also seeks investments in leveraged buyouts and restructurings. It primarily focuses to invest in retail, restaurant, media, business services, and manufacturing industries. The company was founded in 2002. It was formerly known as GS Carbon Corporation and changed its name to Seaway Valley Capital Corporation in August 2007. Seaway Valley Capital Corporation is based in
SWVL News:
September 24 - Seaway Valley Capital Corporation Announces Herbert Becker to be Named President of Hackett's
Seaway Valley Capital Corporation (OTCBB: SWVL), a diversified holding company with its subsidiary, Hackett's Stores, Inc. (OTC: HCKE), announced that newly hired Vice President Herbert Becker will be promoted to President of Patrick Hackett Hardware Company. The appointment, which was approved by the board of directors earlier this week, will take effect on Monday.
Mr. Becker is a veteran of both the retail and Internet industries. He has over 30 years in retail and retail supply chain management, with more than 20 of those years as a senior executive. His diverse background includes extensive experience with public corporations, Internet companies and on-line shopping and e-commerce.
Mr. Becker stated, "I am pleased by the vote of confidence shown to me, and as I said before and am even surer of today: I believe the core Hackett's brand has value. My focus will be to position it in the marketplace to maximize this value." Mr. Becker has focused on streamlining current operations, diversifying product mix to attract a broader customer base, and aggressively pursuing an e-commerce division. Mr. Becker added, "Our first priority as Hackett's is to re-establish our long standing relationships with our premier vendors one by one, and I am optimistic we are making progress on this front." Mr. Becker can be reached at hbecker@hackettsonline.com.
Along with a number of financial and consulting positions, Mr. Becker served as a senior executive for one of
EVOLUTION FUELS INCORPORATED (OTC: EVFL)
"Up 100.00% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/EVFL.php
The Company endeavors to market renewable transportation fuels at retail fuel stations that will provide blends of ethanol from 10% to 85% (E10 to E85), and biodiesel blends from 5% to 20% (B5 to B20). The Company's plan calls for the development of a chain of renewable fuel stations that extend from Texas to Mississippi that will be a combination of "Evolution Fuels"-branded fuel stations/convenience stores and western-motif truck stops modeled after the Willie's Place Truck Stop in Carl's Corner, TX.
EVFL News:
September 24 - Evolution Fuels Announces Board Authorization of Stock Purchase Program
Evolution Fuels, Inc. (OTC: EVFL) (the "Company") announced that its Board of Directors authorized a stock repurchase program under which up to ten billion shares of its outstanding common stock may be acquired in the open market over the next six months at the discretion of management.
The shares will be purchased from time to time at prevailing market prices, through open market or unsolicited negotiated transactions, depending upon market conditions. Under the program, the purchases will be funded from available working capital, and the repurchased shares will be held in treasury or used for ongoing stock issuances such as issuances under employee stock plans. There is no guarantee as to the exact number of shares that will be repurchased by the Company, and the Company may discontinue purchases at any time that management determines additional purchases are not warranted.
Evolution Fuels' CEO, Dennis McLaughlin, remarked, "The Board's approval of this program reflects our confidence in Evolution Fuels' future. Repurchasing stock demonstrates our commitment to enhancing stockholder value."
LUNA INNOVATIONS INCORPORATED (NASDAQ: LUNA)
"Up 94.64% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/LUNA.php
Luna Innovations Incorporated develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in
LUNA News:
September 18 - Luna Innovations Receives NASDAQ Notification Regarding Bid Price; Grace Period Granted Through March 15, 2010
Luna Innovations Incorporated (Nasdaq: LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced that the Company has received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company’s common stock closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days, the Company has been provided 180 calendar days, or until March 15, 2010, to regain compliance with the minimum bid price requirement. In addition, should the Company satisfy the criteria for initial listing on The NASDAQ Capital Market (except for bid price) as of March 15, 2010, the Company will be entitled to a second 180-calendar day period, through September 13, 2010, to regain compliance with the minimum bid price requirement. The Company will regain compliance with NASDAQ’s minimum bid price requirement if the bid price of its common stock closes at $1.00 or higher for a minimum of ten consecutive business days during the compliance period. This notice does not affect the Company’s listing on NASDAQ at this time.
As previously announced on September 8, 2009, the NASDAQ Listing Qualifications Panel determined to transfer the Company’s listing to The NASDAQ Capital Market and to continue the listing of the Company’s common stock subject to several conditions, including the Company’s emergence from Chapter 11 reorganization by December 31, 2009.
GOIP GLOBAL INCORPORATED (OTC: GOIG)
"Up 36.67% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/GOIG.php
GoIP Global, Inc. operates as a mobile media company in the
GOIG News:
September 25 - GoIP Global, Inc. Finalizes
GoIP Global, Inc. (OTC: GOIG) announces a company update to their previous news release. Further to the company news announcement of Sept. 17 where, among other things, GoIP Global, Inc. introduced three targeted foreign merger candidates, the company is pleased to announce the successful closing of the merger.
Again, two of these companies are based in
Yezhifeng Innovation Media and Design Inc. specializes in media, fashion, window and interior designs; its website is located at http://ezf.518d.net.
Wuhan Modern Foreign Language and Culture Media Group, Inc. carries one of the most popular English educational publishing and translation brands in Mainland China, one of its main educational publishing portals at www.wmmenglish.com. English education in Mainland
The company will also add the following four directors and officers (five in total) to GoIP Global, Inc. as of October 1, 2009.
Ike H. Sutton, John Baird, Phillip Welsh, Parry Long, and the 5th are to be appointed by the
More updates will follow shortly, from U.S.A,
ECOTALITY INCORPORATED (OTCBB: ETLY)
"Up 38.75% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/ETLY.php
ECOtality, Inc., headquartered in
ETLY News:
September 25 - Skymark Research Initiates Independent Research Coverage On ECOtality, Inc.
Skymark Research, a leading provider of small- and micro-cap independent investment research, has initiated coverage on ECOtality, Inc. (OTCBB: ETLY). Skymark Research is currently offering a complimentary trial subscription. To view the company's research go to www.skymarkresearch.com.
STEM CELL THERAPY INTERNATIONAL (OTCBB: SCII)
"Up 41.54% on Friday"
Detailed Quote: http://www.otcpicks.com/quotes/SCII.php
Stem Cell Therapy International, Inc., through its wholly owned subsidiary, Stem Cell Therapy International Corp., engages in licensing of stem cell technology and the sale of stem cell products, as well as the provision of information, education, and referral services. It provides allo stem cell biological solutions that are used in the treatment of patients suffering from degenerative disorders of the human body, such as Alzheimer's Disease, Parkinson's Disease, ALS, leukemia, muscular dystrophy, multiple sclerosis, arthritis, spinal cord injuries, brain injury, stroke, heart disease, liver and retinal disease, and diabetes, as well as certain types of cancer. The company's stem cell biological solutions can be used to alleviate the side effects of chemotherapy. Its principal stem cell products are solutions containing allo stem cell biological solutions, either adult stem cells, and stem cells that are extracted from umbilical cord blood. It intends to offer biological solutions containing stem cell products primarily in the
SCII News:
September 25 - Stem Cell Therapy International, Inc. Announces Merger With Histostem and Launching of AmStem International, Inc.
Stem Cell Therapy International, Inc. (OTCBB: SCII) announces the execution of the Reorganization and Stock Purchase Agreement ("the Agreement") with Histostem Co., Ltd., a Korean company ("Histostem" and together with SCII, "the parties"). This results in one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a
David Stark, SCII President and CEO, has been working closely with Histostem's management to finalize the Agreement, and is now working to secure the supply channels that will strengthen the Company's cash flow. Immediate plans include launching a worldwide distribution of existing cosmetic products, including a unique stem cell facial cream. Additional revenue is expected from the development of proprietary technologies from Dr. Han Hoon, CEO of Histostem, who will be working together with AmStem to bring new products to the
Highlights of Histostem include:
* Histostem has the one of the world's largest, fully accredited repository of cord blood units (CBUs) and stem cells in the world (more than twice as large as its nearest competitor); with over 80,000 CBUs ready for immediate transfer. (See more details on Histostem below.)
* Histostem is the only company in the world to have full KFDA approval to use its cord blood derived stem cells directly for the treatment of disease. Clinical trials have been in progress for over 2 years to treat diseases such as Buerger's, Alzheimer's and Parkinson's, as well as Diabetes Mellitus, Hair Loss and ALS.
* Histostem has successfully developed a popular stem cell facial cream for the rejuvenation of skin, which is ready for worldwide distribution.
"The response to our stem cell cream has been extremely positive," states Mr. Stark, "and because we have a proven market presence in
Clinical trials will be upgraded immediately, leveraged by the vast experience of Mr. Stark and his colleagues, who have a combined 30 years' experience in international regulatory affairs. New and improved trials will be run in
"We are absolutely thrilled and bursting with pride to have persevered in finalizing this Agreement with Histostem," adds Mr. Stark. "The quality of the science, market-ready products and meticulous quality control values of Histostem will catapult us into the forefront of the international stem cell marketplace. Our Korean partners are some of the most well-respected scientists in the field," he declares.
Andrew Norstrud, CFO, announces, "This is the first step in the completion of merging these two companies. We will now begin an aggressive investor awareness campaign to enlighten our current and potential investors about the unique opportunity that this merged company has to offer. We believe that we are well positioned in the market to quickly increase our combined world-wide revenue with new stem cell based cosmetic products and the supply of stem cells for research. With the appropriate level of capital, we expect to make significant progress on our research and development objectives for future stem cell applications."
Additional development of Histostem technology by AmStem will include ensuring that their vast stockpile of CBUs is available to patients in need around the world. "We will be making inroads to pool our accredited cord blood bank with other international repositories to facilitate the use of the CBUs by patients in the fastest, most accurate way possible," Mr. Stark announces.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.